Shoulder Innovations announced FDA clearance and commercial launch of the N-22 Humeral Head, a titanium implant designed for shoulder surgery patients with metal hypersensitivity. This new product complements their earlier N-22 Glenosphere implant, expanding options for patients who experience allergic reactions to metal implants. The company aims to enhance surgical care by providing metal-sensitive implant options for both anatomic and reverse total shoulder arthroplasty procedures. This launch supports Shoulder Innovations' growth and strengthens relationships with surgeons and surgical centers across the U.S.
KeyBanc initiated coverage on Air Products and Chemicals with a 'Sector Weight' rating, signaling expected performance in line with its sector. Despite the neutral outlook, the company showed strong profitability with a 110 basis point rise in adjust...
RH reported strong Q2 financial results, with earnings per share of $2.70 far exceeding analyst estimates of $0.38 and revenue of $922.20 million beating the $915.09 million forecast. This performance comes despite a recent 25% drop in RH's stock pri...
Tenon Medical's stock surged 116% after repaying $5.16 million in convertible debt, removing dilution risk for shareholders. Wealthfront also rose 15% following strong quarterly earnings that beat expectations. Digital Brands Group and PicoCELA saw s...
Kroger is set to release its earnings report on September 11, 2026, with analysts expecting earnings per share around $1.05-$1.06 and revenues near $34.64-$34.68 billion. Despite growth in digital sales and fresh product categories, the company faces...
On the day GameStop released its earnings report, an insider purchased $1 million worth of company shares. This move suggests strong confidence in the company's future despite market uncertainties. Insider buying often signals positive expectations a...
